MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
批准号:
7893120
负责人:
Mahendra Damarla
金额:
$16.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-15 至 2014-06-30
关键词:
AcuteAcute Lung InjuryApoptosisApoptosis RegulatorApoptoticBlood VesselsBlood capillariesCellsComplexDataDevelopmentDiseaseEdemaEndothelial CellsEnzymesEventFunctional disorderHeat Shock Protein 27Homologous GeneHypoxiaIn VitroIncidenceInjuryInstructionLungMAP Kinase GeneMAPK14 geneMechanical StressMechanical ventilationMechanicsMediatingMediator of activation proteinMitogen-Activated Protein KinasesMitogensModelingMolecularMolecular ChaperonesMorbidity - disease rateMusPathogenesisPathway interactionsPermeabilityPhosphorylationProtein KinaseProteinsPulmonary EdemaResearch PersonnelRespiratory SystemRoleSeveritiesSignal TransductionStressStretchingSupportive careSyndromeTestingTherapeuticTidal VolumeTissuesVascular PermeabilitiesVentilatorabstractingcapillarycaspase-3human MAPK14 proteinin vivoinsightinterestlung injurymortalitynew therapeutic targetnovelpressurepulmonary vascular permeabilityresponse
中文摘要
描述(由申请人提供):急性肺损伤(ALI)是一种发病率和死亡率很高、治疗选择有限的毁灭性疾病。机械通气(MV)是ALI的主要支持疗法,随着对其不良影响的认识,呼吸机相关性肺损伤(VALI)中肺血管通透性的变化引起了人们越来越多的兴趣。低潮气量肺策略仍然是ALI/VALI唯一被证实有效的支持性治疗方法。因此,需要专门针对Alia/ALI屏障破坏机制的新疗法。近年来,内皮细胞凋亡被认为是VALI早期发病机制中的一个必要事件。此外,p38丝裂原活化蛋白(MAP)激酶,一种已知的内皮细胞凋亡的中介,在MV的损伤模式下被激活。然而,参与介导VALI发生和严重程度的p38 MAP激酶下游效应因子仍不清楚。P38 MAP和其下游的MAPK激活蛋白激酶MK2(MK2)的激活导致小分子热休克蛋白27(HSP27)的磷酸化,HSP27是一种已知的细胞凋亡调节因子。此外,热休克蛋白25(热休克蛋白27‘S小鼠同源物)的磷酸化与热休克蛋白MV介导的细胞凋亡和肺水肿有关。然而,MK2或HSP25参与VALI发生的具体机制(S)尚不清楚。这项建议将通过体外机械应激模型和建立的野生型和MK2-/-小鼠VALI模型来验证MK2介导的HSP27的磷酸化对于促进HVT MV介导的细胞凋亡和由此导致的肺水肿至关重要的假说。这一应用的具体目的是:1)明确MK2在体外促进机械应激诱导的细胞凋亡中的作用;2)确定HSP25/27的磷酸化在体外机械应激诱导的细胞凋亡中的作用;3)确定HSP25/27的磷酸化在体内HVT MV介导的细胞凋亡和由此产生的肺血管通透性中的作用。相关性(见说明书):机械通气虽然是治疗许多疾病的基石,但有可能加重和引起从头开始的肺损伤。我们已经确定了一种途径和一种可能的机制,它与机械通气所致损伤的调节有关。我们希望进一步的洞察将有助于确定新的治疗靶点。(摘要结束)
英文摘要
DESCRIPTION (provided by applicant): Acute lung injury (ALI) is a devastating illness with very high morbidity and mortality and limited therapeutic options. The recognition of the deleterious effects of mechanical ventilation (MV), the mainstay supportive therapy for ALI, has led to increasing interest in the pathways involved in pulmonary vascular permeability observed in ventilator-associated lung injury (VALI). Low tidal volume lung strategies remain the only supportive treatment of ALI/VALI with proven efficacy. Therefore, novel therapies that will specifically target mechanisms involved in barrier disruption in ALIA/ALI are needed. Endothelial cell apoptosis has been recently implicated as a necessary event in the early pathogenesis of VALI. Additionally, the p38 mitogen activated protein (MAP) kinase, a known mediator of endothelial cell apoptosis is activated in response to injurious modes of MV. However, the downstream effectors of p38 MAP kinase involved in mediating the development and severity of VALI remain unknown. Activation of p38 MAP kinase and its downstream effector MAPK-activated protein kinase MK2 (MK2) leads to phosphorylation of the small heat shock protein 27 (HSP27), a known regulator of apoptosis. In addition, phosphorylation of HSP25 (HSP27's murine homologue) correlates with HVT MV mediated apoptosis and pulmonary edema. However, the specific mechanism(s) by which MK2 or HSP25 contribute to the development of VALI are unknown. This proposal will test the hypothesis that MK2-mediated phosphorylation of HSP27 is critical for promoting HVT MV mediated apoptosis and resultant pulmonary edema using an in vitro mechanical stress model and an established murine model of VALI in wild type and MK2-/- mice. The specific aims of this application are to: 1) Define the role of MK2 in promoting mechanical stress-induced apoptosis in vitro; 2) Define the role of HSP25/27 phosphorylation in mechanical stress-induced apoptosis in vitro; and 3) Determine the role for HSP25/27 phosphorylation in HVT MV mediated apoptosis and resultant pulmonary vascular permeability in vivo. RELEVANCE (See instructions): Mechanical ventilation, although the cornerstone of treatment for many disorders, has the potential to exacerbate and cause de novo lung injury. We have identified a pathway and a potential mechanism that is relevant in mediating injury due to mechanical ventilation. We hope that further insight will help identify novel therapeutic targets. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MK2 and pulmonary hypertension
-
批准号:10491169
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2021
-
负责人:Mahendra Damarla
-
依托单位:
MK2 and pulmonary hypertension
-
批准号:10677828
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2021
-
负责人:Mahendra Damarla
-
依托单位:
MK2 and pulmonary hypertension
-
批准号:10312993
-
项目类别:
-
资助金额:$75.8万
-
财政年份:2021
-
负责人:Mahendra Damarla
-
依托单位:
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
-
批准号:8286945
-
项目类别:
-
资助金额:$16.09万
-
财政年份:2009
-
负责人:Mahendra Damarla
-
依托单位:
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
-
批准号:8496607
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2009
-
负责人:Mahendra Damarla
-
依托单位:
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
-
批准号:8100257
-
项目类别:
-
资助金额:$16.22万
-
财政年份:2009
-
负责人:Mahendra Damarla
-
依托单位:
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung Injury
-
批准号:7713110
-
项目类别:
-
资助金额:$16.12万
-
财政年份:2009
-
负责人:Mahendra Damarla
-
依托单位:
Role of MAP Kinase Signaling in Ventilator-Associated Lung Injury
-
批准号:7485792
-
项目类别:
-
资助金额:$5.29万
-
财政年份:2007
-
负责人:Mahendra Damarla
-
依托单位:
Role of MAP Kinase Signaling in Ventilator-Associated Lung Injury
-
批准号:7332698
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2007
-
负责人:Mahendra Damarla
-
依托单位:
Short-Term Training Program to Increase Diversity in Health-Related Research
-
批准号:10578302
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2006
-
负责人:Mahendra Damarla
-
依托单位:
Short-Term Training Program to Increase Diversity in Health-Related Research
-
批准号:10065514
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2006
-
负责人:Mahendra Damarla
-
依托单位:
Short-Term Training Program to Increase Diversity in Health-Related Research
-
批准号:10306396
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2006
-
负责人:Mahendra Damarla
-
依托单位:
海外基金